These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prolonged Psychosis With Catatonia due to 2,5-Dimethoxy-4-Bromoamphetamine: Case Report and Literature Review. Scarella TM; Teslyar P Psychosomatics; 2019; 60(6):599-602. PubMed ID: 30583875 [No Abstract] [Full Text] [Related]
5. A case of death due to ibogaine use for heroin addiction: case report. Jalal S; Daher E; Hilu R Am J Addict; 2013; 22(3):302. PubMed ID: 23617876 [No Abstract] [Full Text] [Related]
6. Long-QT syndrome induced by the antiaddiction drug ibogaine. Hoelen DW; Spiering W; Valk GD N Engl J Med; 2009 Jan; 360(3):308-9. PubMed ID: 19144953 [No Abstract] [Full Text] [Related]
7. Fatalities temporally associated with the ingestion of ibogaine. Alper KR; Stajić M; Gill JR J Forensic Sci; 2012 Mar; 57(2):398-412. PubMed ID: 22268458 [TBL] [Abstract][Full Text] [Related]
8. Cardiac arrest after ibogaine ingestion. Vlaanderen L; Martial LC; Franssen EJ; van der Voort PH; Oosterwerff E; Somsen GA Clin Toxicol (Phila); 2014 Jul; 52(6):642-3. PubMed ID: 24940646 [No Abstract] [Full Text] [Related]
9. Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. Knuijver T; Belgers M; Markus W; Verkes RJ; van Oosteren T; Schellekens A J Clin Psychopharmacol; 2018 Dec; 38(6):646-648. PubMed ID: 30300292 [No Abstract] [Full Text] [Related]
10. Toxic psychosis after intake of the hallucinogen salvinorin A. Paulzen M; Gründer G J Clin Psychiatry; 2008 Sep; 69(9):1501-2. PubMed ID: 19193352 [No Abstract] [Full Text] [Related]
11. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients. Chouinard G; Annable L; Ross-Chouinard A Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310 [No Abstract] [Full Text] [Related]
12. The anti-addiction drug ibogaine and the heart: a delicate relation. Koenig X; Hilber K Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835 [TBL] [Abstract][Full Text] [Related]
13. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia. Diamond BI; Borison RL Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312 [No Abstract] [Full Text] [Related]
14. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia. Kety SS Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537 [No Abstract] [Full Text] [Related]
15. Tardive psychosis: does it exist? Palmstierna T; Wistedt B Psychopharmacology (Berl); 1988; 94(1):144-5. PubMed ID: 2894699 [No Abstract] [Full Text] [Related]
17. Treating drug dependence with the aid of ibogaine: a retrospective study. Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214 [TBL] [Abstract][Full Text] [Related]
18. Mania following use of ibogaine: A case series. Marta CJ; Ryan WC; Kopelowicz A; Koek RJ Am J Addict; 2015 Apr; 24(3):203-205. PubMed ID: 25877487 [TBL] [Abstract][Full Text] [Related]
19. Supersensitivity psychosis in a case with clozapine tolerance. Ozcan S; Soydan A; Tamam L Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814 [TBL] [Abstract][Full Text] [Related]